-
New Drugs for an Elusive Cancer Target
Medical oncologist and lung cancer expert Roy S. Herbst discusses early data on drugs that target a mutated form of the KRAS protein.
by Anna Azvolinsky
-
Cancer Patient Advocates Find Strength in Numbers
Patient advocates have become a vital part of the San Antonio Breast Cancer Symposium. Opportunities for advocates continue to multiply.
by Marci A. Landsmann
-
Exploring Immunotherapy for Triple Negative Breast Cancer
Following the approval of the first immunotherapy for breast cancer by the U.S. Food and Drug Administration in March 2019, experts at the San Antonio Breast Cancer Symposium discussed avenues for further development.
by Marci A. Landsmann
-
Possible New Treatments for Patients With Metastatic HER2-Positive Breast Cancer
Studies presented at the San Antonio Breast Cancer Symposium show additional treatment options.
by Marci A. Landsmann
-
A Switch From Intravenous to Oral Chemo?
Compared with intravenous paclitaxel, the oral form of the chemotherapy drug was associated with improved tumor shrinkage in metastatic breast cancer patients.
by Ashley P. Taylor
-
Navigating Hospital Discharge Decisions
Patients with advanced cancer often go to rehabilitation facilities after a hospital stay in hopes of gaining the strength for further treatment, but the majority do not go on to receive additional cancer therapy, a study reports.
by Ashley P. Taylor
-
Immunotherapy in the Elderly
Immune checkpoint inhibitors can be effective treatments for elderly people with some types of advanced cancer, but more information is needed on their risks and benefits in this group.
by Emma Yasinski
-
First Immunotherapy Approved for Breast Cancer
Medical oncologist Leisha A. Emens discusses the significance of the first U.S. Food and Drug Administration approval of an immunotherapy treatment for breast cancer.
by Anna Azvolinsky
-
The Genetics of Metastatic Cancer
The multiple tumors in patients with metastatic disease share key genetic traits, a sequencing study shows.
by Anna Azvolinsky
-
Cancer Patients Who Are Parents
Patients who are diagnosed with advanced cancer while parenting young children have special priorities and needs.
by Cheryl Platzman Weinstock
Cancer Talk
Lesbians, bisexual women and transgender men had a longer wait for diagnosis and a higher risk of recurrence.
by Jon Kelvey
Deconstructing Peripheral Neuropathy and Chemo BrainResearchers explore mechanisms of chemotherapy-related neurotoxicity at the AACR Annual Meeting 2023.
by Marci A. Landsmann
AACR Annual Meeting 2023Catch up on all of Cancer Today's coverage from the AACR Annual Meeting 2023.
More Prostate Cancer Patients Choose SurveillanceMen are increasingly opting to put off treatment for low-risk prostate cancer, and doctors say it’s a good thing.
by Kyle Bagenstose
From the AACR
-
The Many Aspects of Early Detection and Interception of Cancer
Early detection is key to improving outcomes from cancer. Research in cancer interception aims to characterize tumors at the earliest stages of development.
-
Translating Personal Tragedy Into the Search for New Cancer Therapeutics
Dr. Patricia LoRusso’s parents both died of cancer when she was a teenager, inspiring her to become an oncologist and develop new treatments for people with cancer.
Video
Bringing Cancer Research to Life: Elizabeth M. Jaffee, MD, FAACR
